40425_2019_823_MOESM3_ESM.docx (13.08 kB)
MOESM3 of Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
journal contribution
posted on 2019-12-07, 04:30 authored by Julie Voeller, Amy Erbe, Jacob Slowinski, Kayla Rasmussen, Peter Carlson, Anna Hoefges, Sabrina VandenHeuvel, Ashley Stuckwisch, Xing Wang, Stephen Gillies, Ravi Patel, Alvin Farrel, Jo Rokita, John Maris, Jacquelyn Hank, Zachary Morris, Alexander Rakhmilevich, Paul SondelAdditional file 3: Table S1. P values of pairwise comparisons of 9464D-GD2 tumor growth curves after treatment corresponding to Fig. 3b. P values of pairwise comparisons of tumor growth curves of untreated intradermal 9464D-GD2 tumors and tumors treated with RT alone, anti-CTLA-4 (CTLA) alone, RT and IT-IC, RT and anti-CTLA-4, or RT and IT-IC and anti-CTLA-4.
